BKI-1369 is a bumped kinase inhibitor. BKI-1369 increases hERG-inhibitory activity (IC50:1.52 μM).

BKI-1369 reduces the parasite burden and disease severity in the gnotobiotic pig model. BKI-1369 has been well characterized for potency, metabolism, stability, toxicity, pharmacokinetics, and is potent against C. parvum in infected mice and calves.

1951431-22-3

C23H27N7O

417.51

BKI-1369

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years